Deeper Dive: Understanding Elevation Oncology Inc (ELEV) Through its Various Ratios

Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

The price of Elevation Oncology Inc (NASDAQ: ELEV) closed at $0.62 in the last session, down -0.24% from day before closing price of $0.63. In other words, the price has decreased by -$0.24 from its previous closing price. On the day, 0.23 million shares were traded. ELEV stock price reached its highest trading level at $0.6386 during the session, while it also had its lowest trading level at $0.6116.

Ratios:

We take a closer look at ELEV’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 17.77 and its Current Ratio is at 17.77. In the meantime, Its Debt-to-Equity ratio is 0.45 whereas as Long-Term Debt/Eq ratio is at 0.45.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Piper Sandler on May 31, 2024, initiated with a Overweight rating and assigned the stock a target price of $10.

On May 14, 2024, Stephens started tracking the stock assigning a Overweight rating and target price of $8.

On March 01, 2024, JMP Securities started tracking the stock assigning a Mkt Outperform rating and target price of $7.JMP Securities initiated its Mkt Outperform rating on March 01, 2024, with a $7 target price.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ELEV now has a Market Capitalization of 36913968 and an Enterprise Value of -35135064.

Stock Price History:

Over the past 52 weeks, ELEV has reached a high of $5.83, while it has fallen to a 52-week low of $0.44. The 50-Day Moving Average of the stock is 8.13%, while the 200-Day Moving Average is calculated to be -74.07%.

Shares Statistics:

According to the various share statistics, ELEV traded on average about 699.77K shares per day over the past 3-months and 537780 shares per day over the past 10 days. A total of 59.12M shares are outstanding, with a floating share count of 52.03M. Insiders hold about 11.99% of the company’s shares, while institutions hold 66.13% stake in the company. Shares short for ELEV as of 1731628800 were 6015749 with a Short Ratio of 8.60, compared to 1728950400 on 5948373. Therefore, it implies a Short% of Shares Outstanding of 6015749 and a Short% of Float of 10.75.

Most Popular